Medical-Psychological Correction of Anxiety-Depressive Disorders in Systemic Lupus Erythematosus
DOI:
https://doi.org/10.61841/rsdfqq55Keywords:
systemic lupus erythematosus, depression, anxiety, HADS, psychopharmacotherapy, Gestalt therapy.Abstract
According to a study’s date, psycho-emotional disorders in rheumatic diseases are caused by anxiety-depressive disorders, which are 7-15 times higher than in the general population and account for 89%. [1,6,7.] According to recent data, the prevalence of depression in patients diagnosed with systemic lupus erythematosus is on average 47% [3]. According to other scientists, depressive episodes accounted for 27%, and dysthymia was identified as a manifestation of these depressive disorders. Mild depressive mood that lasted for more than 2 years was observed in 6% of patients, adaptation disorders were detected in 16%, and generalized anxiety disorders in 7% of patients. Overall, anxiety-depressive disorders were detected in more than half (56%) of the patients [4,5]. Therefore, the diagnosis of anxiety-depressive disorders in patients with systemic lupus erythematosus requires the use of psychopharmacotherapy. However, the use of psychotropic drugs alone, along with basic treatment, is not effective enough. Facilitating the course of the disease requires patients to use psychotherapy in order to improve their quality of life. The purpose of the study: to study and estimate medical-psychological correction of anxiety-depressive disorders in systemic lupus erythematosus.
Downloads
References
1. “I.G. Malkin-Pykh Techniques of gestalt and cognitive therapy ": Eksmo; Moscow; 2004 ISBN 5-699-07115-6
2. Harchenko S.A. 1 Sins R.A. 1 Suleymanova G.P. 1 Myakishev M.V. 2 Zborovskaya I.A.- Psychological featuresof patients with systemic lupus erythematosus; Modern problems of science and education.- 2015.- No. 5
3. Brey R. L., Holliday S. L., Saklad A. R. et al. Neuropsychiatric syndromes in lupus. Neurology, 2002, 58, 1214
1220
4. Denton F., Sharpe L., Schrieber L. Cognitive bias in systemic lupus erythematosus. Eur. J. Pain, 2005, 9, 1, 5-14 ;Hermosillo-Romo D., Brey R. L. Diagnosis and management of patients with neuropsychiatric systemic lupuserythematosus (NPSLE). Best Pract. & Res. Clin. Rheumatol., 2002, 16 (2), Р.229-244.).
5. Kozora E., Ellison M.C., West S. Depression, fatigue, and pain in systemic lupus erythematosus (SLE):relationship to the American College of Rheumatology SLE neuropsychological battery. Arthr. and Rheum. 2006; 55:628—35
6. Margaretten M., Julian L., Katz P., Yelin E. Depression in patients with rheumatoid arthritis: description, causes and mechanisms. Int. J. Clin. Rheumtol. 2011; 6 (6): 617—23. ;
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
